GENMAB A has a total of 29 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2003. It filed its patents most often in Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are METHERESIS TRANSLATIONAL RES S A, GURNEY AUSTIN and IMMUNOTECH DEV INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 29 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Electrotherapy | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Parren Paul | 20 |
#2 | Satijn David | 11 |
#3 | Schuurman Janine | 10 |
#4 | Verploegen Sandra | 7 |
#5 | Labrijn Aran Frank | 6 |
#6 | Van Den Brink Edward | 6 |
#7 | Van De Winkel Jan | 6 |
#8 | Neijssen Joost J | 6 |
#9 | Rademaker Rik | 6 |
#10 | Altintas Isil | 5 |
Publication | Filing date | Title |
---|---|---|
KR20180101479A | Antibody and preparation for its drug conjugate | |
KR20180004292A | Monoclonal antibodies against c-met | |
KR20140033240A | Antibodies against cd38 for treatment of multiple myeloma |